source
- Telemedicine firm begins offering GLP-1 medications to treat addictionA telemedicine company announced it will now prescribe GLP-1 class drugs to patients with substance-use disorders through its virtual platform. GLP-1 medications, originally approved for diabetes…
- FDA appoints permanent heads for CDER and CBER amid pending commissioner confirmationThe Department of Health and Human Services announced that Michael Davis, MD, PhD, and Karim Mikhail will become the permanent directors of the Centers for Drugs Evaluation and Research and the Cen…